Updated 13/09/2026
Elevance Health, one of the largest Centers for Medicare & Medicaid Services (CMS) contractors managing Medicare Advantage plans, has agreed to pay $342 million to the federal government to resolve billing disputes. The settlement follows an investigation into allegations that the insurer overcharged the government for beneficiary care.
Key takeaways
- Elevance Health paid $342 million to CMS to settle billing allegations without admitting wrongdoing
- The CMS had threatened to block new patient enrollments in Elevance’s Medicare Advantage plans as enforcement leverage
- This settlement reflects growing federal scrutiny of Medicare Advantage billing practices across the industry
According to reporting from KFF Health News, the payment represents a resolution to a probe into whether Elevance Health submitted inflated claims to CMS. The company agreed to the settlement as the federal agency threatened enforcement actions that would have restricted the company’s ability to recruit new beneficiaries into its plans, a significant commercial threat to the health insurer.
Medicare Advantage Enforcement Actions Intensify
CMS has escalated oversight of major insurers managing beneficiary care under federal contract, 2023–2024
Source: KFF Health News, 2024 | Georgian Medical Journal News
Why CMS Moved Against Elevance Health
The Centers for Medicare & Medicaid Services investigation centered on allegations that Elevance Health submitted risk adjustment claims—payments meant to reflect the complexity of beneficiary illnesses—that were not adequately supported by clinical documentation. According to KFF Health News, such billing disputes have become a focal point of federal regulatory attention as Medicare Advantage enrollment has grown to encompass roughly half of all Medicare beneficiaries.
Risk adjustment is a core mechanism through which CMS pays Medicare Advantage insurers. The system is designed to account for the medical complexity of each beneficiary—sicker patients generate higher payments—but audits have repeatedly found that some insurers claim diagnoses that lack clinical basis in member medical records. This practice inflates federal spending without corresponding improvements in care.
Enforcement Leverage and the Threat of Enrollment Restrictions
According to KFF Health News, the CMS had signalled its intent to bar Elevance Health from enrolling new Medicare Advantage beneficiaries—a sanction that would have severely constrained the company’s commercial growth. This enforcement tool proved decisive: the threat of enrollment restrictions created sufficient pressure to prompt settlement negotiations.
The settlement structure allows Elevance Health to avoid admitting liability while still transferring $342 million to the federal treasury. For CMS, the payment represents both a financial recovery and a signal to other major Medicare Advantage insurers that billing compliance will be rigorously enforced. Medicare Advantage plans now cover approximately 28 million beneficiaries, according to recent CMS enrollment data, making the industry a substantial focus of federal auditing resources.
Broader Pattern of Medicare Advantage Oversight
This settlement arrives amid a documented pattern of CMS enforcement actions targeting billing practices in the Medicare Advantage sector. Health policy experts have noted that the scale of federal scrutiny reflects concerns about unsustainable growth in Medicare Advantage payments relative to traditional Medicare. The Centers for Medicare & Medicaid Services has stated publicly that improving billing accuracy is a strategic priority for programme integrity.
Elevance Health’s settlement may also influence compliance practices at competitor insurers, as companies weigh the financial and reputational costs of audit findings against the cost of enhanced documentation and clinical review processes. Industry observers note that settlements of this magnitude—in the hundreds of millions—create precedent for future enforcement negotiations.
Elevance Health agreed to pay $342 million to the Centers for Medicare & Medicaid Services to resolve allegations of overbilled risk adjustment claims in Medicare Advantage plans.
— KFF Health News reporting, 2024
What this means
Frequently asked questions
What is risk adjustment in Medicare Advantage?
Risk adjustment is a payment mechanism that allows CMS to compensate Medicare Advantage insurers at higher rates for beneficiaries with more complex medical conditions. According to CMS policy, each diagnosis claimed by an insurer must be supported by clinical documentation in the member’s medical record. When diagnoses are claimed without clinical basis, federal payments are inflated.
Why did CMS threaten to block Elevance’s new enrollments?
Enrollment restrictions are among the most potent enforcement tools available to CMS because they directly threaten an insurer’s revenue growth. By threatening to bar new Medicare Advantage enrollments, CMS creates immediate business pressure to negotiate settlement, as reported by KFF Health News.
Will this settlement affect my benefits if I’m an Elevance Health member?
No. The settlement is a financial arrangement between Elevance Health and CMS. According to the terms reported by KFF Health News, beneficiary benefits, premiums, and coverage will not change as a result of this agreement.
The Elevance Health settlement signals that CMS is prepared to use its enforcement authority aggressively to address billing compliance in the Medicare Advantage sector. As the programme continues to grow and absorb a larger share of Medicare spending, federal auditing and enforcement capacity will likely remain a central focus of programme administration and industry compliance strategy.
Source: Medicare Advantage Company Pays $342M to Government in Midst of Billing Probe, KFF Health News
🗺️ Find certified Georgian healthcare providers: sheniekimi.ge — Georgia Health Map · 998 clinics · 6,600+ doctors · 2,296 pharmacies
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Editorial standards. This article was produced under the GMJ News editorial process, with oversight by the GMJ Editorial Board. Our editorial process. Spotted an error? Contact the editorial team.
